AIM ImmunoTech Inc.
AIM · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2 | $5 | $27 | $32 |
| Short-Term Investments | $2 | $8 | $7 | $16 |
| Receivables | $0 | $1 | $2 | $2 |
| Inventory | $0 | -$0 | $0 | $0 |
| Other Curr. Assets | $0 | $1 | $0 | $0 |
| Total Curr. Assets | $4 | $15 | $36 | $50 |
| Property Plant & Equip (Net) | $1 | $1 | $1 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $3 | $2 | $2 | $2 |
| Long-Term Investments | $0 | $0 | $0 | -$25 |
| Tax Assets | $0 | $0 | $0 | $25 |
| Other NC Assets | $1 | $2 | $1 | $1 |
| Total NC Assets | $4 | $5 | $4 | $7 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $9 | $19 | $40 | $58 |
| Liabilities | – | – | – | – |
| Payables | $6 | $6 | $0 | $0 |
| Short-Term Debt | $3 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $2 | $1 | $0 |
| Total Curr. Liab. | $10 | $9 | $1 | $1 |
| LT Debt | $0 | $0 | $1 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | -$24 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $24 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $1 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $1 | $1 | $0 |
| Total Liabilities | $10 | $9 | $2 | $1 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $1 | $1 | $1 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$427 | -$410 | -$381 | -$361 |
| AOCI | $0 | -$0 | $0 | $0 |
| Other Equity | $425 | $419 | $418 | $417 |
| Total Equity | -$1 | $10 | $38 | $57 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $9 | $19 | $40 | $58 |
| Net Debt | $1 | -$5 | -$26 | -$32 |